| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Adolfo G Erustes, Vanessa C Abílio, Claudia Bincoletto, Mauro Piacentini, Gustavo J S Pereira, Soraya S Smail. Cannabidiol induces autophagy via CB Brain research. 2024-12-22. PMID:39710053. |
cannabidiol induces autophagy via cb numerous studies have explored the role of cannabinoids in neurological conditions, chronic pain and neurodegenerative diseases. |
2024-12-22 |
2024-12-25 |
Not clear |
| Atalia Ferreira Lima Flôr, Samuel Duarte-Maia, Francineide Fernandes-Costa, Rayane Maria Pessoa de Souza, Valdir de Andrade Braga, Sandra Lia do Amaral, Sandra Rodrigues Mascarenhas, José Luiz Brito-Alves, Debora Simões Almeida Colombari, Josiane Campos Cru. Chronic cannabidiol treatment induces cardiovascular improvement in renovascular hypertensive rats. Journal of hypertension. 2024-10-01. PMID:39351852. |
cannabidiol (cbd) is increasingly studied for its therapeutic potential in neurodegenerative diseases. |
2024-10-01 |
2024-10-03 |
rat |
| Shiying Dong, Hongwei Zhao, Meng Nie, Zhuang Sha, Jiancheng Feng, Mingqi Liu, Chuanxiang Lv, Yupeng Chen, Weiwei Jiang, Jiangyuan Yuan, Yu Qian, Honggang Wan, Chuang Gao, Rongcai Jian. Cannabidiol alleviates neurological deficits after traumatic brain injury by improving intracranial lymphatic drainage. Journal of neurotrauma. 2024-03-30. PMID:38553903. |
cannabidiol (cbd) has the potential to address metabolic imbalances and improve cognitive functions in neurodegenerative diseases, but its specific effect on tbi remains unclear. |
2024-03-30 |
2024-04-01 |
mouse |
| Yanying Li. Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging. Molecular biology reports. vol 51. issue 1. 2024-01-16. PMID:38227160. |
cannabidiol (cbd), the major non-psychoactive phytocannabinoid extracted from cannabis sativa, has recently emerged as a potential candidate for delaying aging and a valuable therapeutic tool for the treatment of aging-related neurodegenerative diseases due to its antioxidant and anti-inflammation properties. |
2024-01-16 |
2024-01-18 |
Not clear |
| Adedeji O Adenusi, Hezborn M Magacha, Chisom M Nwaneki, Olamide A Asifat, Eugene N Anno. Cannabis Use and Associated Gastrointestinal Disorders: A Literature Review. Cureus. vol 15. issue 7. 2023-08-14. PMID:37575784. |
it is widely used for recreational purposes, while its therapeutic benefits have been extensively explored in the us. for several years, cannabis has been used for the treatment of diverse health conditions, including pain management, anti-inflammatory effects, and spasticity associated with multiple sclerosis and other neurodegenerative diseases. |
2023-08-14 |
2023-08-16 |
Not clear |
| Ilya Eydelman, Na'ama Zehavi, Valeria Feinshtein, Dinesh Kumar, Shimon Ben-Shabat, Amnon C Sinto. Cannabidiol-Loaded Nanoparticles Based on Crosslinked Starch: Anti-Inflammatory Activity and Improved Nose-to-Brain Delivery. Pharmaceutics. vol 15. issue 7. 2023-07-29. PMID:37513990. |
cannabidiol (cbd) has previously been shown to inhibit inflammatory cytokine production in both in vitro and in vivo studies of neurodegenerative diseases. |
2023-07-29 |
2023-08-14 |
Not clear |
| Arosh S Perera Molligoda Arachchig. Marijuana's potential in neurodegenerative diseases: an editorial. AIMS neuroscience. vol 10. issue 2. 2023-07-10. PMID:37426772. |
marijuana's potential in neurodegenerative diseases: an editorial. |
2023-07-10 |
2023-08-14 |
Not clear |
| Nandi Niloy, Tousif Ahmed Hediyal, Chandrasekaran Vichitra, Sharma Sonali, Saravana Babu Chidambaram, Vasavi Rakesh Gorantla, Arehally M Mahalakshm. Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review. Biomolecules. vol 13. issue 1. 2023-01-21. PMID:36671547. |
multiple preclinical and clinical investigations have explored the beneficial effects of cannabis in various neurocognitive and neurodegenerative diseases affecting the cognitive domains. |
2023-01-21 |
2023-08-14 |
Not clear |
| Bruna Stefane Alves de Oliveira, Debora Sandrini Milanezi, Priscila do Val Gonzaga, Fernanda Rabello Detoni, Renato Nery Sorian. The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol. Heliyon. vol 8. issue 12. 2022-12-22. PMID:36544841. |
the gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol. |
2022-12-22 |
2023-08-14 |
Not clear |
| Manikandan Palrasu, Lillianne Wright, Manish Patel, Lindsey Leech, Scotty Branch, Shea Harrelson, Saeed Kha. Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We? Medical cannabis and cannabinoids. vol 5. issue 1. 2022-12-05. PMID:36467783. |
for example, cannabinoids, the most popular and biologically active chemicals in cannabis, aid in many clinical ailments, including pain, inflammation, epilepsy, sleep disturbances or insomnia, multiple sclerosis, anorexia, schizophrenia, neurodegenerative diseases, anti-nausea, and most importantly, cancer. |
2022-12-05 |
2023-08-14 |
Not clear |
| Rose Chesworth, David Cheng, Chloe Staub, Tim Kar. Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse model. Frontiers in pharmacology. vol 13. 2022-10-14. PMID:36238565. |
cannabidiol is a promising potential therapeutic for neurodegenerative diseases, including alzheimer's disease (ad). |
2022-10-14 |
2023-08-14 |
mouse |
| Elisa Landucci, Costanza Mazzantini, Daniele Lana, Maura Calvani, Giada Magni, Maria Grazia Giovannini, Domenico E Pellegrini-Giampietr. Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model. Neurobiology of disease. 2022-10-14. PMID:36240948. |
in the last years the interest on the non-psychoactive compounds present in cannabis sativa has massively increased, and cannabidiol (cbd) has been shown to be effective in the treatment of different types of neurological disorders and neurodegenerative diseases such as epilepsy, ischemia, multiple sclerosis and alzheimer's disease. |
2022-10-14 |
2023-08-14 |
Not clear |
| Bing-Tian Xu, Meng-Fan Li, Ke-Chun Chen, Xing Li, Ning-Bo Cai, Jiang-Ping Xu, Hai-Tao Wan. Mitofusin-2 mediates cannabidiol-induced neuroprotection against cerebral ischemia in rats. Acta pharmacologica Sinica. 2022-10-13. PMID:36229600. |
cannabidiol (cbd) reportedly exerts protective effects against many psychiatric disorders and neurodegenerative diseases, but the mechanisms are poorly understood. |
2022-10-13 |
2023-08-14 |
rat |
| John Staton Laws, Scott D Smi. Evaluating Cannabis sativa L.'s neuroprotection potential: From bench to bedside. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 107. 2022-10-09. PMID:36209703. |
the psychoactive properties of cannabis sativa l. have been recognized for thousands of years and now with burgeoning access to medicinal formulations globally, research has turned to re-evaluate cannabis and its myriad phytochemicals as a potential treatment and adjunctive agent for neurodegenerative diseases. |
2022-10-09 |
2023-08-14 |
Not clear |
| Romola Cavet, Juliet Sostena, Albert Huang, Paul Hauser, Luke D. Effects of Cannabidiol in a Caenorhabditis Elegans Amyotrophic Lateral Sclerosis Model. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35555765. |
cannabidiol, the second most prevalent cannabinoid in the cannabis sativa plant, is a potential therapeutic tool for als due to its antioxidant, anti-inflammatory, and anti-spasticity effects, as well as its complementary role in treating other neurodegenerative diseases. |
2022-05-13 |
2023-08-13 |
caenorhabditis_elegans |
| Zhizhen Wang, Peng Zheng, Yuanyi Xie, Xi Chen, Nadia Solowij, Katrina Green, Yee Lian Chew, Xu-Feng Huan. Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 35. issue 5. 2021-07-27. PMID:33817834. |
cannabidiol (cbd), a phytocannabinoid from the cannabis sativa plant, exhibits a broad spectrum of potential therapeutic properties for neurodegenerative diseases. |
2021-07-27 |
2023-08-13 |
human |
| Yi Yang, Rupali Vyawahare, Melissa Lewis-Bakker, Hance A Clarke, Albert H C Wong, Lakshmi P Kotr. Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors. Molecules (Basel, Switzerland). vol 25. issue 15. 2021-03-19. PMID:32751516. |
cannabis is widely used as a therapeutic drug, especially by patients suffering from psychiatric and neurodegenerative diseases. |
2021-03-19 |
2023-08-13 |
human |
| Franciele F Scarante, Melissa A Ribeiro, Ana F Almeida-Santos, Francisco S Guimarães, Alline C Campo. Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders. Frontiers in pharmacology. vol 11. 2021-02-23. PMID:33613284. |
cannabidiol (cbd) is a phytocannabinoid with a broad-range of therapeutic potential in several conditions, including neurological (epilepsy, neurodegenerative diseases, traumatic and ischemic brain injuries) and psychiatric disorders (schizophrenia, addiction, major depressive disorder, and anxiety). |
2021-02-23 |
2023-08-13 |
Not clear |
| Madilyn Coles, Georgia Watt, Fabian Kreilaus, Tim Kar. Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of Frontiers in pharmacology. vol 11. 2021-01-12. PMID:33424597. |
medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of alzheimer's disease (ad) is a neurodegenerative disease that causes behavioral and cognitive impairments. |
2021-01-12 |
2023-08-13 |
Not clear |
| María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés-Montero, Javier Garzón, Pilar Sánchez-Blázque. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. Molecular brain. vol 11. issue 1. 2019-01-07. PMID:30223868. |
cannabidiol (cbd), the major non-psychotomimetic compound present in the cannabis sativa plant, exhibits therapeutic potential for various human diseases, including chronic neurodegenerative diseases, such as alzheimer's and parkinson's, ischemic stroke, epilepsy and other convulsive syndromes, neuropsychiatric disorders, neuropathic allodynia and certain types of cancer. |
2019-01-07 |
2023-08-13 |
human |